global consortium of scientists is well on the way to making a synthetic genome for the yeast Saccharomyces cerevisiae 1 -the first synthetic genome for a member of the group of organisms known as eukaryotes, which includes plants, animals and fungi. Embedded within the extensively redesigned 'version 2.0' genome of S. cerevisiae (Sc2.0) are DNA sequences that form part of a system known as Synthetic Chromosome Rearrangement and Modification by LoxPmediated Evolution (SCRaMbLE). This system allows extensive reorganization of the genome to be triggered on demand, generating Sc2.0 variants that have diverse genetic make-ups and characteristics. Sc2.0 is therefore a versatile platform that can be easily modified and evolved to produce yeasts that have desired attributes 2 . A collection of seven papers [3] [4] [5] [6] [7] [8] [9] published in Nature Communications demonstrates the immense potential of Sc2.0 for engineering and understanding yeast.
To enable SCRaMbLE, a palindromic DNA sequence known as loxPsym is inserted after every non-essential gene in the synthetic genome. In the presence of the enzyme Cre recombinase, the loxPsym sites undergo recombination with each other -that is, the loxPsym sequences break in the middle, and the broken ends can then join up with any other available loxPsym ends. This process results in genes being randomly deleted, inverted, relocated and duplicated.
In the original design of the SCRaMbLE system 10 , Cre recombinase was produced only once during the lifetime of a cell, and was fused to a protein domain that binds oestradiol molecules -which allowed the enzyme to be activated by adding oestradiol to the yeast's growth medium, providing an on-off switch for genome rearrangement (Fig. 1) . However, some 'background' genome rearrangement occurred even without oestradiol activation. This version of SCRaMbLE was functional 11, 12 , but four of the new papers now report improvements to the system. Shen et al. 3 have modified SCRaMbLE to produce multiple pulses of Cre recombinase (instead of just one per lifetime) to increase rearrangement events while reducing background Cre recombinase activity. Jia et al. 4 have developed a SCRaMbLE variant in which both oestradiol and galactose molecules are required to activate rearrangement, also reducing background rearrangement. Hochrein et al. 5 have engineered Cre recombinase so that it is activated by red light, providing a new way to control SCRaMbLE. And Luo et al. 6 have introduced a reporter DNA sequence into a synthetic yeast strain, which allows cells that have undergone SCRaMbLE-induced genome rearrangement to be easily distinguished from those that have not. All four improvements facilitate effective and efficient implementation of SCRaMbLE.
An important application of SCRaMbLE is to generate genetically diverse pools of yeast mutants from which strains that have industrially valuable characteristics can be isolated. For example, yeasts can be genetically engineered to produce useful compounds, and Blount et al. 7 show that SCRaMbLE can generate yeast strains that produce antibiotics (violacein or penicillin) in greater quantities than could be achieved without SCRaMbLE. Blount and colleagues also used the system to produce yeast strains that use the sugar xylose for growth more effectively than strains produced without SCRaMbLE; xylose is poorly used by wildtype yeast, but is abundant in biomass and is therefore an attractive alternative to the sugars normally used to feed yeast in industrial applications. And Luo et al. have used their SCRaMbLE variant to accelerate the isolation of yeast strains that are tolerant to various stress factors, such as ethanol, heat and acetic acid.
Jia and co-workers report that production of β-carotene molecules can be drastically increased if SCRaMbLE is used in diploid yeasts, which have two copies of the genome, instead of haploids, which have a single copy. Similarly, Shen et al. used SCRaMbLE in diploids to improve the heat or caffeine tolerance of hybrid yeasts (organisms produced by crossing two different yeast species or subspecies).
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Yeast shuffles towards a diverse future
A redesigned yeast genome is being constructed to allow it to be extensively rearranged on demand. A suite of studies reveals the versatility of the genomeshuffling system, and shows how it could be used for biotechnology applications. Both groups observed genome rearrangements in diploids that involved the deletion of one copy of essential genes. The presence of such rearrangements in improved diploid strains shows that, compared to haploids, diploids are more robust to deleterious deletions during SCRaMbLE. This in turn allows a greater number of beneficial rearrangements to be manifested. Although it is premature to claim that SCRaMbLE is a universal tool for engineering yeast, taken together, the various findings [3] [4] [5] [6] [7] certainly show that it has great potential for generating yeasts for a wide range of purposes.
Wu et al. 8 have taken SCRaMbLE out of cells and used it in vitro with purified Cre recombinase to generate different genetic arrangements of the β-carotene biosynthetic pathway. They thus discovered arrangements that increase β-carotene production compared with the original pathway. By contrast, Liu et al. 9 used an in vitro method involving recombinase enzymes separate from the SCRaMbLE system, to rapidly generate different versions of β-caroteneand violacein-producing pathways and to identify highly productive ones. They then flanked the DNA sequences of the best pathways with loxPsym, and used SCRaMbLE to randomly incorporate the pathways at loxPsym sites in the synthetic yeast genome. SCRaMbLE concurrently rearranged the resulting genomes, allowing yeast strains to be optimized for the production of the desired compounds. These two papers illustrate the versatility of the basic SCRaMbLE concept and how it can be used in innovative ways.
So where next for Sc 2.0? So far, six synthetic chromosomes of Sc2.0 have been completed 13 , and consortium members are working fulltime to construct the remaining ten. The seven new papers show that researchers are eager to work with the newly available synthetic chromosomes to see how SCRaMbLE techniques can generate useful yeast variants and improve our understanding of the fundamental processes and properties of yeast. Thousands of loxPsym sites will be present in the fully assembled Sc 2.0 genome, and so the number of genomic structures that can be generated by SCRaMbLE is immense -which suggests that it should be possible to produce a yeast variant that displays any desired set of characteristics.
Nevertheless, SCRaMbLE systems are still in their infancy. Further improvements are needed, along with tools that maximize the potential of SCRaMbLE-based techniques. For example, the screening of SCRaMbLE-modified yeast has generally relied on visible cues, such as growth rate and colour (both β-carotene and violacein are pigments that colour the yeast cells). Luo and colleagues' reporter offers a useful new screening tool, but high-throughput methods are also needed that can identify yeast strains that produce large amounts of colourless chemicals. Crucially, the characterization of genetic rearrangements relies heavily on whole-genome sequencing. The development of more-efficient, cheaper sequencing techniques would allow more strains to be sequenced than is currently possible, to work out and study changes in the genome. Given the promising early results and synergy among the members of the Sc2.0 consortium, the establishment of SCRaMbLE as a staple tool for engineering yeast is highly anticipated. ■ 
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S ome people are born with exceptional sensitivity to sunlight. Fifty years ago, writing in Nature, the biologist James Cleaver 1 reported a study of one such condition, and concluded that a failure of DNA repair was related to the extreme susceptibility of affected individuals to skin cancer. This was the first description of defective DNA repair in a genetically inherited disorder that makes people prone to cancer. The concepts that developed from this work now permeate research into the genetic origins of cancer and its treatment.
Starting in the 1870s, the Viennese dermatologist Moritz Kaposi performed pioneering work that defined a rare disorder characterized by high sensitivity to sunlight. Young patients were severely burned by brief exposure to the sun and acquired frequent skin lesions, and some had a high incidence of skin tumours. Kaposi dubbed the condition xeroderma pigmentosum 2 (XP), using the Greek words for dry, pigmented skin -one of the symptoms of the disease. He recognized that this was a hereditary syndrome, but the underlying cause was not obvious. Little research into XP was then done until the 1960s, when a process called nucleotide excision repair was discovered in bacteria [3] [4] [5] . In this process, enzymes clip out segments of DNA that have been damaged by light and replace them with fresh, undamaged DNA. Mutant bacterial strains were isolated that could be killed by low doses of ultraviolet radiation, and some of these were found to be unable to carry out excision repair 4, 5 . These concepts of DNA repair were then extended to human cells. By 1964, the biologists Robert Painter and Ronald Rasmussen had discovered that UV irradiation of mammalian cells led to a phenomenon that they interpreted as excision repair 6 . In their experiments, cultured human cells were supplied with radioactive molecules (bases) that could be incorporated into DNA. The cells were observed to incorporate new bases after UV irradiation, even when they were not duplicating their genomes, indicating that UV-damaged DNA was being replaced.
In 1967, Cleaver joined Painter's laboratory in San Francisco as a postdoctoral fellow. Cleaver had obtained his PhD at the University of Cambridge, UK, where he had been using radioactive bases to label DNA in human cells. In April of that year, Cleaver read a newspaper article in the San Francisco Chronicle that mentioned research showing that skin cells grown from patients with XP were extraordinarily sensitive to UV radiation 7 . Cleaver raised with Painter the idea that XP might involve a mutation that causes DNA repair to be defective, and suggested investigating this
In retrospect
A catalyst for 50 years of cancer research
In 1968, a defect in DNA repair was found to underlie a disorder that makes people extremely sensitive to sunlight. This finding continues to influence research into the origins, diagnosis and treatment of cancer.
